Related references
Note: Only part of the references are listed.Peptidomimetic α-Acyloxymethylketone Warheads with Six-Membered Lactam P1 Glutamine Mimic: SARS-CoV-2 3CL Protease Inhibition, Coronavirus Antiviral Activity, and in Vitro Biological Stability
Bing Bai et al.
JOURNAL OF MEDICINAL CHEMISTRY (2022)
High-throughput screening assays for SARS-CoV-2 drug development: Current status and future directions
Tuan Xu et al.
DRUG DISCOVERY TODAY (2021)
Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2
Catherine Z. Chen et al.
FRONTIERS IN PHARMACOLOGY (2021)
Biological activity-based modeling identifies antiviral leads against SARS-CoV-2
Ruili Huang et al.
NATURE BIOTECHNOLOGY (2021)
SARS-CoV-2 M-pro inhibitors with antiviral activity in a transgenic mouse model
Jingxin Qiao et al.
SCIENCE (2021)
Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19
Britton Boras et al.
NATURE COMMUNICATIONS (2021)
Potent Noncovalent Inhibitors of the Main Protease of SARS-CoV-2 from Molecular Sculpting of the Drug Perampanel Guided by Free Energy Perturbation Calculations
Chun-Hui Zhang et al.
ACS CENTRAL SCIENCE (2021)
A head-to-head comparison of the inhibitory activities of 15 peptidomimetic SARS-CoV-2 3CLpro inhibitors
Subramanyam Vankadara et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2021)
Indole Chloropyridinyl Ester-Derived SARS-CoV-2 3CLpro Inhibitors: Enzyme Inhibition, Antiviral Efficacy, Structure-Activity Relationship, and X-ray Structural Studies
Arun K. Ghosh et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Structure-Guided Design of Conformationally Constrained Cyclohexane Inhibitors of Severe Acute Respiratory Syndrome Coronavirus-2 3CL Protease
Chamandi S. Dampalla et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Rational Design of Hybrid SARS-CoV-2 Main Protease Inhibitors Guided by the Superimposed Cocrystal Structures with the Peptidomimetic Inhibitors GC-376, Telaprevir, and Boceprevir
Zilei Xia et al.
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2021)
Bardoxolone and bardoxolone methyl, two Nrf2 activators in clinical trials, inhibit SARS-CoV-2 replication and its 3C-like protease
Qi Sun et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
A machine learning platform to estimate anti-SARS-CoV-2 activities
Govinda B. KC et al.
NATURE MACHINE INTELLIGENCE (2021)
Coronavirus biology and replication: implications for SARS-CoV-2
Philip V'kovski et al.
NATURE REVIEWS MICROBIOLOGY (2021)
Predictive Models for Human Organ Toxicity Based on In Vitro Bioactivity Data and Chemical Structure
Tuan Xu et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2020)
The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak
Hussin A. Rothan et al.
JOURNAL OF AUTOIMMUNITY (2020)
The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China
Yongshi Yang et al.
JOURNAL OF AUTOIMMUNITY (2020)
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
Nanshan Chen et al.
LANCET (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2
Renhong Yan et al.
SCIENCE (2020)
Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs
Sangeun Jeon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
Jun Lan et al.
NATURE (2020)
Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
Zhenming Jin et al.
NATURE (2020)
Drug Discovery Strategies for SARS-CoV-2
Zeenat A. Shyr et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2020)
Machine learning classification can reduce false positives in structure-based virtual screening
Yusuf O. Adeshina et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
ACCORD: A Multicentre, Seamless, Phase 2 Adaptive Randomisation Platform Study to Assess the Efficacy and Safety of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalised Patients: A structured summary of a study protocol for a randomised controlled trial
Tom Wilkinson et al.
TRIALS (2020)
Broad Anti-coronavirus Activity of Food and Drug Administration-Approved Drugs against SARS-CoV-2 In Vitro and SARS-CoV In Vivo
Stuart Weston et al.
JOURNAL OF VIROLOGY (2020)
Identification of SARS-CoV-2 3CL Protease Inhibitors by a Quantitative High-Throughput Screening
Wei Zhu et al.
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2020)
Virtual and In Vitro Antiviral Screening Revive Therapeutic Drugs for COVID-19
Giovanni Bocci et al.
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2020)
Identifying SARS-CoV-2 Entry Inhibitors through Drug Repurposing Screens of SARS-S and MERS-S Pseudotyped Particles
Catherine Z. Chen et al.
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2020)
A cell-based large-scale screening of natural compounds for inhibitors of SARS-CoV-2
Zhe-Rui Zhang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Bigger is better in virtual drug screens
David E. Gloriam
NATURE (2019)
Exploiting machine learning for end-to-end drug discovery and development
Sean Ekins et al.
NATURE MATERIALS (2019)
A Random Forest Sub-Golgi Protein Classifier Optimized via Dipeptide and Amino Acid Composition Features
Zhibin Lv et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2019)
AQ-13-an investigational antimalarial drug
Juliana Boex Mengue et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2019)
Computer-aided diagnosis of ground-glass opacity pulmonary nodules using radiomic features analysis
Jing Gong et al.
PHYSICS IN MEDICINE AND BIOLOGY (2019)
Classifying heatwaves: developing health-based models to predict high-mortality versus moderate United States heatwaves
G. Brooke Anderson et al.
CLIMATIC CHANGE (2018)
A perspective on multi-target drug discovery and design for complex diseases
Rona R. Ramsay et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2018)
Vacquinol-1 inducible cell death in glioblastoma multiforme is counter regulated by TRPM7 activity induced by exogenous ATP
Philip Sander et al.
ONCOTARGET (2017)
An oncogenic Ezh2 mutation induces tumors through global redistribution of histone 3 lysine 27 trimethylation
George P. Souroullas et al.
NATURE MEDICINE (2016)
Modelling the Tox21 10 K chemical profiles for in vivo toxicity prediction and mechanism characterization
Ruili Huang et al.
NATURE COMMUNICATIONS (2016)
Predicting Hepatotoxicity Using ToxCast in Vitro Bioactivity and Chemical Structure
Jie Liu et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2015)
pROC: an open-source package for R and S plus to analyze and compare ROC curves
Xavier Robin et al.
BMC BIOINFORMATICS (2011)
The NCGC Pharmaceutical Collection: A Comprehensive Resource of Clinically Approved Drugs Enabling Repurposing and Chemical Genomics
Ruili Huang et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Extended-Connectivity Fingerprints
David Rogers et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2010)
A novel Bcl-XL inhibitor Z36 that induces autophagic cell death in Hela cells
Jian Lin et al.
AUTOPHAGY (2009)
The pharmacokinetics of maropitant, a novel neurokinin type-1 receptor antagonist, in dogs
H. A. Benchaoui et al.
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS (2007)
Quantitative high-throughput screening: A titration-based approach that efficiently identifies biological activities in large chemical libraries
James Inglese et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Virtual screening of chemical libraries
BK Shoichet
NATURE (2004)
Synthesis and structure-activity relationship of 2-amino-3-heteroaryl-quinoxalines as non-peptide, small-molecule antagonists for interleukin-8 receptor
JJ Li et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2003)
Share Paper
